appo@xmu.edu.cn
Toggle navigation
HOME
BROWSE
By ADRs
By Drugs
TOOL
ADR Similarity Search
Structure Similarity Search
DOWNLOAD
HELP
Available mirror site
Adverse Drug Reaction Classification System
For ADR
For Drug
Search
----------All----------
ADR Term
ADReCS ID
MedDRA Code
MeSH ID
Drug Name
Drug ID
ATC Code
DrugBank ID
KEGG ID
PubChem ID
CAS RN
Molecular Formula
QuickSearch
Fuzzy Search
Accurate Search
ADR Ontology
ADR Term
Ascites
ADR ID
BADD_A00347
ADR Hierarchy
02
Cardiac disorders
02.05
Heart failures
02.05.04
Heart failure signs and symptoms
02.05.04.002
Ascites
07
Gastrointestinal disorders
07.07
Peritoneal and retroperitoneal conditions
07.07.01
Peritoneal and retroperitoneal disorders
07.07.01.001
Ascites
09
Hepatobiliary disorders
09.01
Hepatic and hepatobiliary disorders
09.01.05
Hepatobiliary signs and symptoms
09.01.05.003
Ascites
Description
A disorder characterized by accumulation of serous or hemorrhagic fluid in the peritoneal cavity. [CTCAE] Accumulation or retention of free fluid within the peritoneal cavity. [MeSH]
MedDRA Code
10003445
MeSH ID
D001201
;
D001201
;
D002915
;
D001201
;
D001202
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Ascites | Ascites chylous | Chylous ascites | Peritoneal effusion | Peritoneal effusion (chronic)
ADR Related Proteins
Protein Name
UniProt AC
TTD Target ID
Not Available
Not Available
Not Available
Drugs Leading to the ADR
Drug ID
Drug Name
ADR Frequency (FAERS)
ADR Severity Grade (FAERS)
BADD_D02429
Clomifene
0.002091%
BADD_D02434
Cinacalcet
-
-
BADD_D02436
Atorvastatin
-
-
BADD_D02438
Enoxaparin
0.003673%
BADD_D02445
Solifenacin
0.000772%
BADD_D02453
Midostaurin
0.000799%
BADD_D02459
Dalteparin
0.012704%
BADD_D02460
Ganirelix
0.019603%
BADD_D02462
Methylnaltrexone
0.001220%
BADD_D02464
Fingolimod
-
-
BADD_D02470
Nintedanib
-
-
BADD_D02473
Sodium chloride
0.000604%
BADD_D02477
Tenofovir alafenamide
0.001447%
BADD_D02480
Alectinib
0.000533%
BADD_D02483
Ribociclib
0.001332%
BADD_D02486
Niraparib
0.001598%
BADD_D02503
Telotristat ethyl
-
BADD_D02504
Lorlatinib
0.000533%
BADD_D02510
Rucaparib
0.004529%
BADD_D02524
Ivosidenib
0.000533%
The 8th Page
First
Pre
8
Total 8 Pages